Plasma chromogranin a in prostatic carcinoma and neuroendocrine tumors

Journal of Urology

Volumn 157, Issue 2, 1997, Pages 565-568

  Kimura, Noriko ^a   Hoshi, Senji ^a   Takahashi, Masaru ^a   Takeha, Satoshi ^a   Shizawa, Soichiro ^a   Nagura, Hiroshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

chromogranins; neuroendocrine tumors; prostatic neoplasms

Indexed keywords

CHROMOGRANIN A; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER STAGING; CARCINOID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY;

EID: 0031021417     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65203-0     Document Type: Article

References (20)

1. Blaschko, H., Comline, R. S., Schneider, F. J., Silver, M. and Smith, A. D.: Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulations. Nature, 215: 58, 1967.
2. Deftos, L. J.: Chromogranin A - Its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endoer. Rev., 12: 181, 1991.
3. Kimura, N., Sasano, N., Yamada, R. and Satoh, J.: Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumour, medullary thyroid carcinoma and carcinoid tumour. Virchows Arch. A, 413: 33, 1988.
4. Hsiao, R. J., Seeger, R. C., Yu, A. L. and O'Connor, D. T.: Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival. J. Clin. Invest., 85: 1555, 1990.
5. O'Connor, D. T. and Deftos, L.: Secretion of chromogranin A by peptide-producing endocrine neoplasms. New Engl. J. Med., 314: 1145, 1986.
6. O'Connor, D. T. and Deftos, L.: How sensitive and specific is measurement of plasma chromogranin A for the diagnosis of neuroendocrine neoplasia? Ann. N. Y. Acad. Sci., 493: 379, 1987.
7. Sobol, R. E., Memoli, V. and Deftos, L. J.: Hormone-negative, chromogranin A-positive endocrine tumors. New Engl. J. Med., 320: 444, 1989.
8. Stabile, B. E., Howard, T. J., Passaro, E., Jr. and O'Connor, D. T.: Source of plasma chromogranin A elevation in gastrinoma patients. Arch. Surg., 125: 451, 1990.
9. Syversen, U., Mignon, M., Bonfils, S., Kristensen, A. and Waldum, H. L.: Chromogranin A and pancreastatin-like immunoreactivity in serum of gastrinoma patients. Acta Oncol., 32: 161, 1993.
10. Abrahamsson, P. A., Wadström, L. B., Alumets, J., Falkmer, S. and Grimelius, L.: Peptide-hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate. Path. Res. Prac., 182: 298, 1987.
11. di Sant'Agnese, P. A.: Neuroendocrine differentiation in carcinoma of the prostate-diagnostic, prognostic, and therapeutic implications. Cancer, suppl., 70: 254, 1992.
12. Dillen, L., DeBlock, J., Van Lear, L. and De Potter, W.: Enzymelinked immunosorbent assay for chromogranin A. Clin. Chem., 35: 1934, 1989.
13. Syversen, U., Jacobsen, M. B., O'Connor, D. T., Rønning, K. and Waldum, H. L.: Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans-correspondence in patients with neuroendocrine neoplasia. Neuropeptides, 26: 201, 1994.
14. Kimura, N., Ishikawa, T., Sasaki, Y., Sasano, N., Onodera, K., Shimizu Y., Kimura, I., Steiner, D. F. and Nagura, H.: Expression of prohormone convertase, PC2, in ACTH-producing thymic carcinoid with elevated plasma corticotropin-releasing hormone. J. Clin. Endocr. Metab., 81: 390, 1996.
15. Aprikian A. G., Cordon-Cardo, C., Fair, W. R., Zhang, Z.-F., Bazinet, M., Hamdy, S. M. and Reuter, V. E.: Neuroendocrine differentiation in metastatic prostatic adenocarcinoma. J. Urol., 151: 914, 1994.
16. Tarle, M. and Radoś, N.: Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring - comparative study of a multiple tumor marker assay. Prostate, 19: 23, 1991.
17. Kadmon, D., Thompson, T. C., Lynch, G. R. and Scardino, P. T.: Elevated plasma chromogranin-A concentrations in prostatic carcinoma. J. Urol., 146: 358, 1991.
18. Bonkhoff, H., Stein, U., Remberger, K: Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate. Virchows Archiv A, 423: 291, 1993.
19. Kimura N., Miura, W., Noshiro, T., Mizunashi, K., Hanew, K., Shimizu, K., Watanabe, T., Shibukawa, S., Sohn, H. E., Abe, K., Miura, Y. and Nagura, H.: Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones. Endocr. J., in press.
20. Nobels, F. R., de Herder, W. W., Kwekkeboom, D. J., Coopmans, W., Mulder, A., Bouillon, R. and Lamberts, S. W.: Serum chromogranin A in the differential diagnosis of Cushing's syndrome. Eur. J. Endocr., 131: 589, 1994.